oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The value of a statistical life in Sweden: a review of the empirical literature
Örebro University, Swedish Business School at Örebro University. (Nationalekonomi)ORCID iD: 0000-0003-1172-1076
Örebro University, Örebro University School of Business.ORCID iD: 0000-0003-1113-7478
2012 (English)In: Health Policy, ISSN 0168-8510, E-ISSN 1872-6054, Vol. 108, no 2-3, p. 302-310Article in journal (Refereed) Published
Abstract [en]

Recent focus on cost-benefit/socio-economic assessment of government "life-saving" programmes within public health, pharmaceutics, transport, and civil contingencies has spurred a wave of empirical research on the value of a statistical life (VSL) in Sweden. This paper provides an overview of the received evidence from a range of studies in one country and over a relatively short time period. A literature search was conducted in Econlit, Pubmed, Google Scholar and in bibliographies of published papers. Twelve studies on VSL with a total of 48 VSL estimates, published with data from Sweden from 1996 onwards, were identified. Among all estimates VSL varies from 9 to 1121 million SEK (€0.9-121 million). Based on a set of additional quality inclusion criteria, as used also in a recent global review of VSL studies, the sample is restricted to 9 studies with a total of 29 VSL estimates with VSL varying from 9 to 98 million SEK (€0.9-10.6 million). The raw mean among these estimates is 34.6 million SEK (€3.7 million) and the median is 23 million SEK (€2.5 million). Currently, official authorities in Sweden recommend a VSL of 22 million Swedish kronor (€2.4 million). We also point out important concerns regarding validity of these estimates: primarily the problem that VSL is significantly related to the size of the mortality risk reduction showing significant scale insensitivity, in contrast to theoretical assumptions but in line with previous empirical findings.

Place, publisher, year, edition, pages
Elsevier, 2012. Vol. 108, no 2-3, p. 302-310
Keywords [en]
Willingness to pay; Value of a statistical life; Stated preferences; Revealed preferences; Economic evaluation
National Category
Economics
Research subject
Economics
Identifiers
URN: urn:nbn:se:oru:diva-31162DOI: 10.1016/j.healthpol.2012.09.007ISI: 000313535300022PubMedID: 23084655Scopus ID: 2-s2.0-84870059141OAI: oai:DiVA.org:oru-31162DiVA, id: diva2:654710
Note

Funding Agency:

Swedish Civil Contingencies Agency

Available from: 2013-10-08 Created: 2013-10-08 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Hultkrantz, LarsSvensson, Mikael

Search in DiVA

By author/editor
Hultkrantz, LarsSvensson, Mikael
By organisation
Swedish Business School at Örebro UniversityÖrebro University School of Business
In the same journal
Health Policy
Economics

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 427 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf